AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ImmunityBio, Inc. Director's Dealing 2021

Apr 5, 2021

31529_dirs_2021-04-05_711b1298-f433-4495-aec0-8f62136b01fe.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: ImmunityBio, Inc. (IBRX)
CIK: 0001326110
Period of Report: 2021-03-09

Reporting Person: Sachs David C. (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	18860	Direct

Footnotes

F1: This amendment is being filed to include shares of common stock held by the reporting person. These shares were not included in the Form 3 filed on March 11, 2021.